Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Black Diamond Therapeutics Inc (NQ: BDTX )

1.635 +0.005 (+0.31%)
Streaming Delayed Price Updated: 11:59 AM EDT, Mar 20, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 33,135
Open 1.630
Bid (Size) 1.620 (1)
Ask (Size) 1.650 (1)
Prev. Close 1.630
Today's Range 1.620 - 1.700
52wk Range 1.180 - 4.080
Shares Outstanding 36,213,654
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
12 Health Care Stocks Moving In Monday's Intraday Session
 
Via Benzinga
Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
From Black Diamond Therapeutics, Inc
Via Globe NewsWire

Performance

YTD
-11.14%
-11.14%
1 Month
-39.89%
-39.89%
3 Month
+13.54%
+13.54%
6 Month
-34.60%
-34.60%
1 Year
-47.43%
-47.43%

More News

Read More
Black Diamond Therapeutics to Present at the Cowen 43rd Annual Health Care Conference
From Black Diamond Therapeutics, Inc
Via Globe NewsWire
Why Jupiter Wellness Shares Are Trading Lower By Around 40%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Black Diamond Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
From Black Diamond Therapeutics, Inc
Via Globe NewsWire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Black Diamond Therapeutics Announces Changes to Board of Directors
From Black Diamond Therapeutics, Inc
Via Globe NewsWire
Black Diamond Therapeutics Announces Spinout of Launchpad Therapeutics, Inc., an Antibody-Focused Precision Oncology Company
From Black Diamond Therapeutics, Inc
Via Globe NewsWire
Black Diamond Therapeutics to Participate in Upcoming Investor Conferences
From Black Diamond Therapeutics, Inc
Via Globe NewsWire
Black Diamond Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update
From Black Diamond Therapeutics, Inc
Via Globe NewsWire
$3 Million Bet On Taysha Gene Therapies? Check Out These 3 Penny Stocks Insiders Are Buying
Via Benzinga
Black Diamond Therapeutics And 2 Other Penny Stocks Insiders Are Aggressively Buying
Via Benzinga
Black Diamond Therapeutics Presents Preclinical Data on BDTX-1535 and BDTX-4933 at the 34th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
From Black Diamond Therapeutics, Inc
Via Globe NewsWire
$1.8 Million Bet On MacroGenics? Check Out These 3 Penny Stocks Insiders Are Buying
Via Benzinga
Why IMARA Shares Are Trading Higher By Over 13%; Here Are 22 Stocks Moving Premarket
Via Benzinga
Black Diamond Therapeutic: Q2 Earnings Insights
Via Benzinga
$1 Million Bet On CalAmp? 4 Penny Stocks Insiders are Buying
Via Benzinga
Black Diamond Therapeutic: Q1 Earnings Insights
Via Benzinga
Executives Buy Around $1.6M Of 4 Penny Stocks
Via Benzinga
Black Diamond Cuts 30% Of Its Workforce, Discontinues Drug From its 'MasterKey' Pipeline
Via Benzinga
Executives Buy Around $5M Of 3 Penny Stocks
Via Benzinga
4 Stocks Under $5 Insiders Are Aggressively Buying
Via Benzinga
53 Biggest Movers From Yesterday
Via Benzinga
38 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.